INCAPS and BASi have entered a corporate alliance in which the two CROs will offer complementary services. INCAPS has a focus on proteomics and protein characterization studies using current and emerging technology platforms and BASi is focused on in-life safety and pharmacology assessment of new drug substances with a small molecule focus. BASi chairman and chief executive officer Pete Kissinger commented, “INCAPS has assembled a first-rate team and state-of-the-art instrumentation, i...